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Abstract
Background: Hutchinson-Gilford progeria syndrome (HGPS, OMIM 176670) is a rare sporadic
disorder with an incidence of approximately 1 per 8 million live births. The phenotypic appearance
consists of short stature, sculptured nose, alopecia, prominent scalp veins, small face, loss of
subcutaneous fat, faint mid-facial cyanosis, and dystrophic nails. HGPS is caused by mutations in
LMNA, the gene that encodes nuclear lamins A and C. The most common mutation in subjects with
HGPS is a de novo single-base pair substitution, G608G (GGC>GGT), within exon 11 of LMNA. This
creates an abnormal splice donor site, leading to expression of a truncated protein.
Results: We studied a new case of a 5 year-old girl with HGPS and found a heterozygous point
mutation, G608G, in LMNA. Complementary DNA sequencing of RNA showed that this mutation
resulted in the deletion of 50 amino acids in the carboxyl-terminal tail domain of prelamin A. We
characterized a primary dermal fibroblast cell line derived from the subject's skin. These cells
expressed the mutant protein and exhibited a normal growth rate at early passage in primary
culture but showed alterations in nuclear morphology. Expression levels and overall distributions
of nuclear lamins and emerin, an integral protein of the inner nuclear membrane, were not
dramatically altered. Ultrastructural analysis of the nuclear envelope using electron microscopy
showed that chromatin is in close association to the nuclear lamina, even in areas with abnormal
nuclear envelope morphology. The fibroblasts were hypersensitive to heat shock, and
demonstrated a delayed response to heat stress.
Conclusion: Dermal fibroblasts from a subject with HGPS expressing a mutant truncated lamin A
have dysmorphic nuclei, hypersensitivity to heat shock, and delayed response to heat stress. This
suggests that the mutant protein, even when expressed at low levels, causes defective cell stability,
which may be responsible for phenotypic abnormalities in the disease.
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Background
Hutchinson-Gilford progeria syndrome (HGPS, OMIM
176670) is a rare sporadic disorder with an incidence of 1
per 8 million live births. Birth weight and appearance are
usually normal, but growth typically becomes retarded at
the age of 1 year. Phenotypic features include short stat-
ure, sculptured nose, alopecia, prominent scalp veins,
small face, subcutaneous fat loss, faint mid-facial cyano-
sis, and dystrophic nails. Features occurring in the skin
during late adulthood of normal individuals, such as hair
greying, hair loss, and skin thinning, occur in the first few
years of life in subjects with HGPS [1-3]. Most subjects die
in their teenage years from cardiac complications of coro-
nary artery disease or stroke due to widespread arterioscle-
rosis [2].
The diagnosis of HGPS was formerly based on the criteria
of growth retardation and prematurely aged phenotype in
children. In 2003, however, mutations in the LMNA gene
that encodes nuclear lamins A and C were identified as
responsible for this syndrome [4-6]. As such, HGPS
belongs to the group of diseases caused by mutations in
LMNA, sometimes referred to as "laminopathies," which
also includes disorders of striated muscle, peripheral
nerve and partial lipodystrophy syndromes [7,8]. The
LMNA mutation present in the majority of subjects with
HGPS is a de novo heterozygous base change (GGC>GGT)
within exon 11 of the LMNA gene, which does not cause
an amino acid substitution (G608G) but creates an abnor-
mal splice donor site [4,5].
Nuclear lamins are members of the intermediate filament
protein superfamily [9,10]. They are the building blocks
of the nuclear lamina, a fibrous proteinaceous meshwork
underlying the inner nuclear membrane [11]. Nuclear
lamins have an extra 42 amino acids (six heptads) in coil
1B compared to cytoplasmic intermediate filament pro-
teins [12,13]. Nuclear lamins also contain two unique
sequences: a nuclear localization signal in the tail domain
[14], and, except for lamin C, a carboxyl-terminal CAAX
box (cysteine-aliphatic-aliphatic-any amino acid), a target
for isoprenylation [15-18]. In the human genome, 3 dis-
tinct loci encode lamins. LMNA is located on chromo-
some 1q21.2 [19,20] and encodes 4 lamins by alternative
RNA splicing: A, C, A∆ 10, and C2 [21]. Lamin A is synthe-
sized as a precursor, prelamin A, from which 17 amino
acids are removed from the carboxyl-terminal by endo-
proteolysis after isoprenylation. There are 2 B-type lamin
genes: LMNB1 on chromosome 5q23-q31.1 that encodes
lamin B1 [20,22], and LMNB2 on chromosome 19p13.3
[23] that encodes lamin B2 [24] and lamin B3, an alterna-
tively spliced isoform expressed in germ cells [25].
We recently identified a new female subject with HGPS
from Italy. We now show that she has the most common
heterozygous point mutation, G608G, in LMNA resulting
in expression of the prelamin A mutant with 50 amino
acids deleted from the carboxyl-terminal tail domain. We
analyzed the nuclear morphology and growth characteris-
tics of these fibroblasts, and for the first time demonstrate
that cells from a subject with HGPS exhibit increased sus-
ceptibility to heat stress.
Results
Clinical description of a new subject with HGPS
The female subject is the second child from consanguine-
ous parents (second cousins) (Fig. 1A). The subject's
mother and an uncle (Fig. 1A, red) were affected with
pseudoxanthoma elasticum, an inherited disorder of con-
nective tissue. At birth, the subject had cutaneous xerosis
and mild skin indurations of the lower limbs. At 1 month,
she developed more severe skin stiffening on the lower
limbs, trunk, and extensor areas on the forearms, accom-
panied by functional limitation in leg extension. Mild
perioral cyanosis was also visible. A skin biopsy was per-
formed at 2 years of age and histological analysis revealed
fibrous thickening of the lower dermis, subcutaneous
septa, and fascia, accompanied by a few mucinous depos-
its. Weigert staining showed pronounced rarefactions of
elastic fibers. A dermal fibroblast culture was established
from the biopsy sample. Physical examination of the sub-
ject at age 5 years revealed loss of subcutaneous tissue,
especially on the face and limbs, and thickening of the
skin that appeared shiny and taut in most areas. She also
had a small face with a recessed chin, thin beaked nose,
small ears, prominent eyes, prominent scalp veins, and
alopecia.
Detection of a LMNA mutation encoding a truncated 
prelamin A
We sequenced all 12 exons of LMNA that comprise the
lamin A/C coding region and splice junctions of the sub-
ject's DNA using previously described oligonucleotide
primers [26]. We found a heterozygous C to T transition
at nucleotide 1824 in exon 11 of LMNA, which created a
silent point mutation at codon 608 (GGC>GGT; G608G)
(Fig. 1B). We also sequenced exon 11 from the father (Fig.
1B) and the mother (data not shown) and found no
mutation in either.
Amplification of cDNA fragments by RT-PCR correspond-
ing to nucleotides 1561 to 2010 of prelamin A mRNA
showed that the wild type fragment was 449 nucleotides
and the mutant fragment 299 nucleotides. The mutant
sequence was 150 nucleotides shorter than the wild type,
corresponding to a deletion of 50 amino acids. Figure 2A
shows the sequence of the mutant lamin A cDNA from
nucleotide 1804 (in the codon for amino acid 602) to the
last amino acid codon. The deducted amino acidBMC Cell Biology 2005, 6:27 http://www.biomedcentral.com/1471-2121/6/27
Page 3 of 11
(page number not for citation purposes)
sequence of the mutant from residue 602 to the carboxyl-
terminus is GSGAQSPQNCSIM (Fig. 2A).
Nuclear envelope morphology in HGPS fibroblasts
We examined the nuclear envelope morphology of der-
mal fibroblasts from control individuals and from the
subject with HGPS after 10 or less passages in primary cul-
tures. Cells were fixed and immunostained with anti-
lamin A/C antibodies and examined by confocal micros-
copy. Nuclei of control fibroblasts were mostly regular in
size and shape, and appeared generally round or ovoid
(Fig. 2B, a and b). In contrast, the size of nuclei in the sub-
ject's fibroblasts was more variable, and the nuclear enve-
lopes had convex "blebs" or herniations projecting
towards the cytoplasm (Fig. 2B, c and d). By direct count
of 1,000 cells in 3 different cultures from the subject and
controls, we determined that 19% of nuclei in the sub-
ject's fibroblasts had irregularities in nuclear envelope
shape compared to only 4% of control cells, in which the
dysmorphic nuclei exhibited less severe abnormalities.
Despite abnormalities in nuclear envelope size and shape
in fibroblasts from the subject with HGPS, there were no
gross abnormalities in the localization of lamins A/C (Fig.
2B, c and d) or lamin B1 (Fig. 2C, d). Furthermore, the
vimentin network appeared normal (Fig. 2C, e). Staining
with 4',6-diamidino-2-phenylindole (DAPI) did not
reveal obvious defects in chromatin density (data not
shown).
We further examined the localizations of A-type lamins,
B-type lamins, and emerin, an integral protein of the inner
nuclear membrane, using double labelling immunofluo-
rescence microscopy. We examined the most abnormal
appearing nuclei in the subject's cells, carefully analyzing
the localization of lamin B1 (Fig. 3b) and emerin (Fig. 3f)
compared to A-type lamins (Fig. 3a and 3e). At the nuclear
periphery of the subject's most dysmorphic nuclei, label-
ling of A-type and B-type lamins is super-imposable (Fig.
3c). Even in sites where the nuclear envelope contained
"blebs," both A-type and B-type lamins were colocalized.
Emerin also colocalized with A-type lamins in the same
distribution pattern (Fig. 3g). When intranuclear lamin A/
C labelling was present, emerin was found in the same
structures, suggesting that they represented invaginations
of the nuclear envelope. Concurrent DAPI staining did
not demonstrate a gross detachment between the nuclear
lamina (A-type and B-type lamin labelling) and chroma-
tin, even in the most abnormally shaped nuclei (Fig. 3 a
to d). Lamin A/C, B1 and emerin labelling were in close
apposition to the DNA labelling, suggesting that the
nuclear envelope and lamina remained in close approxi-
mation to chromatin. DNA labelling detected in the her-
niated areas of nuclei also was associated with labelling by
anti-lamin A/C, anti-lamin B1 and anti-emerin antibodies
(Fig. 3d and 3h).
We carried out an ultrastructural analysis of cultured
fibroblasts from the subject with HGPS using transmis-
sion electron microscopy. The electron micrographs
clearly showed that chromatin remained in contact with
the nuclear envelope (Fig. 4a to 4c). Analysis of a dysmor-
phic nucleus with 3 blebs (Fig. 4a) revealed that the chro-
matin also remained attached to the nuclear envelope at
those sites (Fig. 4b and 4c).
Analysis of lamin expression by Western blotting
We performed Western blot analysis on total protein
extractions from cultured fibroblasts at passage number
10. Anti-lamin A/C antibodies that recognize a sequence
predicted to be within the truncated G608G prelamin A
mutant, in addition to lamin A and C bands, detected the
mutant protein in the subject's cells migrating above the
band corresponding to lamin C (Fig. 5, panel Lamin A/C,
lanes 3 and 4, arrow). This protein was not detected in
extracts of control fibroblasts (Fig. 5, panel Lamin A/C,
lanes 1 and 2). In Western blots containing equal
amounts of cell extracts, the lamin A and lamin C signals
were approximately the same for subject and control cells
(Fig. 5; panel Lamin A/C). This was confirmed by densit-
ometric analysis of autoradiograms of 4 separate Western
blots from subject and control cells. In addition, the
Characterization of a new subject with HGPS Figure 1
Characterization of a new subject with HGPS. (A) 
Pedigree of the subject with HGPS. Filled black circle indi-
cates the proband; red circle and square respectively repre-
sent the female (mother of proband) and male (uncle of 
proband) with pseudoxanthoma elasticum (PXE). A diagonal 
line indicates a deceased individual. Double lines indicate 
consanguinity. (B) Short portion of the LMNA sequence 
within exon 11. The paternal sequence (Father) corresponds 
to the wild type LMNA sequence. The affected subject (HGPS 
Patient) has a heterozygous C to T transition (indicated by a 
star) at nucleotide 1824 in exon 11 of the LMNA sequence.BMC Cell Biology 2005, 6:27 http://www.biomedcentral.com/1471-2121/6/27
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Sequencing of the mutant prelamin A cDNA and fibroblast morphology in the subject with HGPS Figure 2
Sequencing of the mutant prelamin A cDNA and fibroblast morphology in the subject with HGPS. (A) Sequence 
of cDNA encoding mutant prelamin A in the subject with HGPS. Mutant prelamin A cDNA sequence from nucleotide 1804 to 
the end of the coding region and the corresponding deduced amino acid sequence are shown. (B) Confocal microscopic analy-
sis of dermal fibroblast in primary culture from a control (a and b) and the subject with HGPS (c and d). Labelling was per-
formed with anti-lamin A/C antibodies. Note the presence of irregularly shaped nuclear envelopes in many of the subject's 
fibroblasts. (C) Double label immunofluorescence microscopic analysis of fibroblasts from an unaffected control (a to c) and 
subject with HGPS (d to f) labelled with anti-lamin B1 (red)) and anti-vimentin (green) antibodies. Bars, 10 µm.BMC Cell Biology 2005, 6:27 http://www.biomedcentral.com/1471-2121/6/27
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signals on Western blots obtained using anti-lamin B1
and anti-emerin antibodies showed no obvious differ-
ences between the subject and unaffected individuals (Fig.
5, panels Lamin B1 and Emerin). Hence, at low passage
number in primary culture, fibroblasts from a subject with
HGPS express a mutant truncated prelamin A, but lamin
Comparison of lamin A/C localization with lamin B1, emerin and chromatin in dysmorphic nuclei of fibroblasts from the subject  with HGPS Figure 3
Comparison of lamin A/C localization with lamin B1, emerin and chromatin in dysmorphic nuclei of fibroblasts 
from the subject with HGPS. Upper panel shows micrographs of fibroblasts from the subject with HGPS labelled with anti-
lamin A/C antibodies (a), anti-lamin B1 antibodies (b), the merged signal (c) and DAPI (d). Lower panel shows micrographs of 
fibroblasts from the same subject labelled with anti-lamin A/C antibodies (e), anti-emerin antibodies (f), the merged signal (g), 
and DAPI (h). Bar, 10 µm.
Ultrastructural analysis of the nuclear envelope in fibroblasts from the subject with HGPS Figure 4
Ultrastructural analysis of the nuclear envelope in fibroblasts from the subject with HGPS. Low magnification 
transmission electron microscopic image of a passage 10 PT001 nucleus showed several herniations (a). Two higher-magnifica-
tion images of the same nucleus at sites of blebs (b and c) showed a close apposition of the chromatin to the nuclear envelope. 
In a, b, and c the nucleus is to the left. Scale bars correspond to 2 µm in panel a, and 500 nm in panels b and c.BMC Cell Biology 2005, 6:27 http://www.biomedcentral.com/1471-2121/6/27
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A, lamin C, lamin B1, and emerin are expressed at approx-
imately normal levels.
Growth rate of fibroblasts from a subject with HGPS in 
early passage primary culture
We examined the growth rate of cultured primary dermal
fibroblasts from the subject with HGPS. At each cellular
passage, the total number of cells from control and
proband was assessed by direct count prior to plating. The
mean number of harvested HGPS fibroblasts was compa-
rable to the number obtained with two control fibroblast
lines derived from unaffected individuals at passage num-
bers in culture below passage 10. Dermal fibroblasts from
the subject with HGPS therefore had a similar growth rate
to the control counterparts and did not exhibit gross cell
cycle defects at low passage numbers in culture.
Dermal fibroblasts from a subject with HGPS are 
hypersensitive to heat stress
To evaluate the resistance to stress of the nuclear envelope,
fibroblasts from the subject with HGPS and control indi-
viduals were heat shocked for 30 minutes at 45°C. Cells
were then either fixed immediately (time 0) or incubated
at 37°C for 24 and 48 hours to allow for recovery. Nuclear
shape was examined by microscopy after labelling with
anti-lamin A/C or anti-lamin B1 antibodies at time 0, 24
hours and 48 hours after heat shock (Fig. 6). In control
cells, nuclear shape and distribution of A-type and B-type
lamins were not altered by heat shock (Fig. 6A a to c and
Fig. 6B g to i, respectively). In contrast, extensive nuclear
deformations appeared in the cells from the subject with
HGPS (Fig. 6A d to f and Fig. 6B m to o). The subject's
fibroblasts showed an increase in the number of cells with
altered nuclei immediately after heat shock. Nuclear enve-
lopes were deformed, many had a ruffled appearance, and
some had "pleats" or "folds" (Fig. 6, d and m, time 0). The
number of irregular nuclei increased to nearly 70 % after
24 hours, as determined by direct count of 1,000 nuclei in
cells on different coverslips. Some nuclei were more
severely affected than others and showed "blebbing" or
nuclear lobe formation 24 hours after heat shock (Fig. 6,
e and n, time 24). This type of nuclear damage was never
observed in the control cells (Fig. 6; a, b, g, and h). At 48
hours after heat shock, nuclei with invaginations were no
longer observed in the fibroblasts from the subject with
HGPS (Fig. 6; f and o), suggesting that the cells with
severely dysmorphic nuclei died and detached from the
coverslips during processing for immunofluorescence
microscopy. Fibroblasts remaining on the coverslips
appeared to have recovered from the stress, as their nuclei
showed a less ruffled appearance and the irregularities
resembled those observed prior to the heat shock (Fig. 6;
f and o, time 48). There was no apparent rearrangement of
the vimentin cytoplasmic intermediate filament network
after heat shock and 24 and 48 hours after recovery in the
subject's and control fibroblasts (Fig. 6; p to r).
Survival rates of fibroblasts subjected to heat shock were
evaluated and compared to unheated cells (Table 1). At 24
hours after recovery, 25% of the subject's cells were lost
compared to the number of cells prior to treatment. In
contrast, the total number of control fibroblasts increased
by 39%. This suggests that growth of control cells was not
significantly affected by heat shock, as they continued to
divide. After 48 hours, the subject's fibroblasts appeared
to have recovered from stress, as the number of cells
increased, reaching approximately the same number of
cells per dish as before heat shock. From 24 hours to 48
hours after heat shock, the number of cells from the sub-
ject with HGPS increased by 30%. Control cells continued
to increase by an average of 36% at 48 hours after heat
shock.
These experiments indicate that control cells recovered
rapidly from heat shock, since no changes were apparent
in their growth rate 24 and 48 hours later. However,
fibroblasts from the subject with HGPS were hypersensi-
tive to heat shock, and the number with dysmorphic
nuclei was high after treatment. Their recovery was only
observed 48 hours after heat shock, when cell numbers
started to increase, suggesting that surviving cells had
begun to divide again.
Discussion
We report another subject with HGPS who has the LMNA
G608G mutation. So far, 21 out of 25 reported cases of
Detection of lamins A and C, lamin B1 and emerin by West- ern blotting in fibroblasts from the subject with HGPS Figure 5
Detection of lamins A and C, lamin B1 and emerin by 
Western blotting in fibroblasts from the subject with 
HGPS. Fibroblasts from unaffected controls (lanes 1 and 2) 
and the subject with HGPS (lanes 3 and 4) were lysed in Lae-
mmli buffer, and whole-cell extracts corresponding to 0.5 × 
106 cells (lanes 1 and 3) and 0.25 × 106 (lanes 2 and 4) were 
analyzed by immunoblotting using anti-lamin A/C (lane: Lamin 
A/C), anti-lamin B1 (lane: Lamin B1) and anti-emerin (lane: 
Emerin) antibodies. Arrowhead points to the position of the 
prelamin A mutant in lanes 3 and 4.BMC Cell Biology 2005, 6:27 http://www.biomedcentral.com/1471-2121/6/27
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Confocal analysis of dermal fibroblasts after heat shock stress Figure 6
Confocal analysis of dermal fibroblasts after heat shock stress. Cells were incubated at 45°C for 30 minutes, then 
either immediately fixed (time 0) or allowed to recover for 24 or 48 hours at 37°C. Cells were processed for indirect immun-
ofluorescence labelling using anti-lamin A/C antibodies (panel A, a to f), anti-lamin B1 antibodies (panel B, g to r) and anti-
vimentin antibodies (panel B j to i and p to r). Control and HGPS fibroblasts are indicated. (A) Fibroblasts were immunostained 
with anti-lamin A/C antibodies. Note the increased number of dysmorphic nuclei in HGPS fibroblasts compared to control 24 
hours after recovery from heat shock. (B) Fibroblasts were immunostained with anti-lamin B1 and vimentin at times indicated 
after heat shock. Bar, 10 µm.BMC Cell Biology 2005, 6:27 http://www.biomedcentral.com/1471-2121/6/27
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HGPS genetically analyzed have this point mutation
[4,5,27], making it a molecular signature for HGPS.
Sequencing of parental DNA, when available, has shown
that none of them carried this mutation, indicating that it
is a de novo mutation. These findings also show that HGPS
is an autosomal dominant disease possibly resulting from
germinal mosaicism [4].
The LMNA G608G mutation creates an abnormal splice
donor site producing mRNA with 150 nucleotides deleted
from the prelamin A coding sequence. The encoded trun-
cated protein is predicted to be missing residues 607 to
656 of prelamin A and to retain the CAAX box for the pre-
nylation at its carboxyl-terminus. As the "upstream" endo-
proteolytic cleavage site of wild type prelamin A is deleted
[15], the truncated prelamin A in HGPS may remain pre-
nylated; however, this remains to be shown
experimentally.
To understand the cellular basis of HGPS, we analyzed the
morphology dermal fibroblasts from our subject, which
express the mutant protein. We studied the distribution of
A-type lamins in primary fibroblast cultures at early cellu-
lar passage numbers (less than or equal to 10) to better
reflect the in vivo distribution of proteins. We observed
nuclear abnormalities in a subpopulation of HGPS
fibroblasts, where dysmorphic nuclei had "blebs" sur-
rounded by A-type lamins. We did not observe defects in
the lamin A/C meshwork in "blebs" of the most dysmor-
phic nuclei, and chromatin distribution appears normal
even within the 'blebs." The fibroblasts did not have gross
anomalies of the localization of lamin B1 or emerin, even
when the lamina network appeared ruffled.
Only a subpopulation of cultured fibroblasts from our
subject with HGPS had dysmorphic nuclei. Furthermore,
the nuclear abnormalities observed in these fibroblasts
may have been less dramatic than those reported in cell
lines from other individuals with HGPS [28]. Nuclear
abnormalities in fibroblasts from our subject with HGPS
also differed from those reported in fibroblasts from sub-
jects with Dunnigan-type familial partial lipodystrophy, a
condition caused by different autosomal dominant
LMNA mutations. Cells from these subjects have defects
in lamin A/C distribution in nuclear envelope "blebs,"
and there is also a loss of lamin B1 staining around the
nuclear envelope "blebs" and sometimes at the nuclear
pores [29]. Despite these subtle differences between cells
from subjects with HGPS and subjects with other lamin-
opathies, generally similar morphological alterations
invariably occur in some portion of cultured fibroblasts
from subjects with different lamin A/C mutations
[21,29,30]. Grossly similar alterations are also observed in
fibroblasts from Lmna knockout mice [31,32]. Based on
these nuclear envelope abnormalities common to all
laminopathies, it appears that A-type lamins play a crucial
role in the maintenance of the size and shape of the
nucleus. These alterations in nuclear morphology could
potentially lead to abnormalities in cell growth or struc-
tural stability.
We did not observe differences in the proliferation of
fibroblasts from our subject with HGPS compared to
fibroblasts from unaffected controls at passage numbers
below 10 in primary culture. A recent report suggested
that, after a certain number of passages, fibroblasts from
subjects with HGPS were no longer able to proliferate at a
similar rate as fibroblasts from unaffected controls [28].
Growth inhibition was recently reported for other cell
lines from subjects with HGPS, where after a certain
number of doublings, the cells rapidly entered a senes-
cence phase [33,34]. Fibroblasts from Lmna  knockout
mice are prone to apoptosis when derived from new-
borns, while fibroblasts derived from knockout embryos
can grow in culture for a restricted number of passages
[30].
With regards to cell stability, we observed that fibroblasts
from our subject with HGPS cells were more susceptible
to damage from heat shock than controls. The subject's
cells in culture had an increased number of dysmorphic
nuclei and enhanced cell death within the first 24 hours
after the heat shock. Fibroblasts from the subject with
HGPS appeared to be able to eventually recover from heat
Table 1: Percentage of cells recovered after heat shock treatment. Values shown are mean percentages (plus or minus standard 
errors, n = 3) of fibroblasts collected from 10 cm culture dishes prior to and 24 hours and 48 hours after heat shock for a period of 30 
minutes at 45°C.
% of fibroblasts recovered after heat treatment
Before heat shock Hours after heat shock
02 44 8
Control 100 97.6 ± 0.9 139.2 ± 1.5 175 ± 2.9
HGPS 100 95.8 ± 1.5 74.6 ± 5.1 104.9 ± 5.8BMC Cell Biology 2005, 6:27 http://www.biomedcentral.com/1471-2121/6/27
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stress, since they started to grow again after a delay of 24
hours. These findings suggest that fibroblasts form
subjects with HGPS are fragile and more readily damaged
or killed after stress. Increased nuclear fragility to mechan-
ical stress and head shock has also been reported in
fibroblasts from mice lacking lamins A and C and human
subjects with Dunnigan-type familial partial lipodystro-
phy [29,35].
Conclusion
Cells from a subject with HGPS and the lamin A G608G
mutation have dysmorphic nuclei and an increased sus-
ceptibility to damage by heat shock. Our findings suggest
that these cells may also be sensitive to other types of
stress, such as metabolic or mechanical. Improving the
cellular response to stress may be one possible way of
helping individuals with HGPS and other laminopathies.
Methods
Clinical material
After obtaining informed consent, we obtained blood
from a subject with a clinical diagnosis of HGPS, her far-
ther, and her mother. Genomic DNA was isolated from
peripheral blood according to standard techniques [36]. A
skin biopsy had been performed from the right leg when
the subject was 2 years of age for histological examination,
and a dermal fibroblast culture was concomitantly estab-
lished from the same tissue sample. Two control dermal
fibroblast cultures were established from neonatal fore-
skin and skin of a 9 year-old who underwent surgery with-
out any known diseases. Primary dermal fibroblasts were
maintained in DMEM containing 15 % fetal calf serum, 2
mM glutamine, 100 IU/ml penicillin, and 100 mg/ml
streptomycin for a maximum of 12 passages. The Colum-
bia University Medical Center Institutional Review Board
approved the use of cells from human subjects.
LMNA sequencing
All exons of the lamin A/C coding region of LMNA and
splice junctions were amplified by PCR from genomic
DNA using primers described previously [26]. Amplified
DNA was sequenced directly using an ABI Prism 310
Automated Sequencer and the ABI Prism Big Dye Termi-
nator Cycle Sequencing Ready Reaction Kit (PE Applied
Biosystems) following purification in a Centriflex Gel Fil-
tration Cartridges (Edge Biosystems). Mutations were
identified by visual inspection and comparison with
sequences generated from unrelated, unaffected individu-
als, and the GeneBank reference sequence.
Prelamin A cDNA sequencing
Total RNA was extracted from cultured dermal fibroblasts
using Trizol reagent according to the manufacturer (Invit-
rogen). Using the forward primer (5' GGCTGCG-
GGAACAGC 3') and the reverse primer (5'
CTGGCAGGTCCC 3'), we amplified by RT-PCR the cDNA
spanning nucleotides 1561 to 2010 of the prelamin A
coding sequence. Amplified DNA products were purified
and subcloned into the pGBT9 (Invitrogen). Clones were
sequenced using the forward and reverse primers
described above. The mutant sequence was verified by
sequencing 3 independent clones generated from 3 differ-
ent RT-PCRs.
Indirect immunofluorescence microscopy
Primary cultures of dermal fibroblasts were grown on
glass coverslips, washed with PBS, fixed in methanol at -
20°C, and then processed for indirect immunofluores-
cence as described previously [37,38]. Rabbit antibodies
directed against A-type and B-type lamins were kindly
provided by Dr. N. Chaudhary and have been previously
described [39,40]. Secondary antibodies were affinity
purified Alexa Fluor 488 goat anti-rabbit or anti-mouse
IgG antibodies (Molecular probes) and Cy3-conjugated
goat anti-rabbit or anti-mouse (Jackson ImmunoResearch
Laboratories). For double immunofluorescence micros-
copy with the rabbit anti-A-type lamin antibodies, we
used a mouse monoclonal anti-emerin clone 4G5
(Novacastra Laboratories) or a previously described
human anti-lamin B antiserum [41], which was kindly
provided by Dr. J.-C. Courvalin. Cells were also examined
with anti-vimentin antibodies [42], kindly provided by
Dr. S. D. Georgatos, and appropriate secondary antibod-
ies. All samples were also counterstained with DAPI
(Sigma-Aldrich) and slides were examined using a confo-
cal microscope.
Transmission Electron Microscopy
Cells were fixed with 2.5% glutaraldehyde in 0.1 M Soren-
son's buffer (PH 7.2) for an hour, and postfixed with 1%
OsO4 in Sorenson's buffer for one hour. Enblock staining
was performed using 1% tannic acid. After dehydration
cells were embedded in a mixture of Lx-112 (Ladd
Research Industries, Inc.) and Embed-812 (EMS, Fort-
washington, PA). Thin sections were cut on a MT-7000
ultramicrotome. Sections were stained with uranyl acetate
and lead citrate, and examined under a JEOL JEM-1200
EXII electron microscope.
Western blot analysis
Total cellular protein extracts were isolated from dermal
fibroblasts in primary cultures at passage number 10.
Total cell number was determined for each culture, and
cell pellets were extracted directly in Laemmli sample
buffer [43]. Cells were lysed and equal amounts of extracts
(corresponding to the same number of cells) were loaded
in parallel on a 6% polyacrylamide gel. After separation
by electrophoresis, proteins were transferred to
nitrocellulose membranes and incubated with blocking
buffer for several hours as described previously [44].BMC Cell Biology 2005, 6:27 http://www.biomedcentral.com/1471-2121/6/27
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Membranes were incubated with primary antibodies,
washed, and then incubated with the corresponding sec-
ondary antibody coupled to horseradish peroxidase (Jack-
son ImmunoResearch Laboratories). Proteins were
visualized using the enhanced chemiluminescence's
detection system (Amersham Pharmacia Biotech). Signals
obtained on the autoradiograms were analyzed by densit-
ometry using Quantity One 1-D analysis software (BioRad
Laboratories) on the scanned images.
Heat shock treatment
Cells were grown in 10 cm diameter dishes in complete
medium and transferred from 37°C to 45°C for 30 min-
utes. Viability was determined prior to heat shock, and at
time 0 (after 30 minutes stress), 24 hours, and 48 hours
after recovery at 37°C. Attached cells were trypsinized at
each time point, collected and counted. For morphologi-
cal analysis, fibroblasts were grown on coverslips and
treated as above. Unheated and heated samples were fixed
in methanol at -20°C, and processed for indirect immun-
ofluorescence as described above.
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